Ipsen Appoints Michelle C. Werner to Lead North American Expansion
Ipsen has appointed Michelle C. Werner as Executive Vice President and President of North America, effective March 2026. A veteran of AstraZeneca and former CEO of Alltrna, Werner is tasked with accelerating growth in Ipsen's largest market across its oncology, rare disease, and neuroscience portfolios.